Colecalciferol as an Add-on Treatment to Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)
Status:
Unknown status
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
This is a multi-centre, double blind, randomised, placebo controlled, parallel group, phase 4
pilot study investigating colecalciferol (vitamin D3) as an add-on treatment to
subcutaneously administered interferon-beta-1b in relapsing-remitting multiple sclerosis
patients.
Phase:
Phase 4
Details
Lead Sponsor:
University of Turku
Treatments:
Cholecalciferol Ergocalciferols Interferon beta-1b Interferon-beta Interferons Vitamin D Vitamins